Global Meningococcal Vaccine Market Growth 2019-2024

Date : Feb 2019

Formats :
Report Code : PMR133888898

Category : Pharmaceutical and Healthcare
No Of Pages : 161

Meningococcal Vaccine Market 2019-2024

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Top-down and bottom-up approaches are used to validate the global Meningococcal Vaccinesize market and estimate the market size for manufacturers, regions segments, product segments and applications.

The market estimations in this report are based on the marketed sale price of Meningococcal Vaccine. The percentage splits, Market Share, and breakdowns of the product segments are derived on the basis of weightages assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Meningococcal Vaccine market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major players in the market are identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, Market Share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYR Pharma & Healthcare Research Center and presented in this report.


According to this study, over the next five years the Meningococcal Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share sales and revenue of key companies in Meningococcal Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Vaccine market by product type, application, key manufacturers and key regions and countries.

This study considers the Meningococcal Vaccine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Quadrivalent
Bivalent
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pneumonia
Meningitis
Bacteremia
Others Arthritis, Conjunctivitis, Urethritis

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Meningococcal Vaccine consumption value & volume by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Meningococcal Vaccine market by identifying its various subsegments.
Focuses on the key global Meningococcal Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Meningococcal Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market growth potential, opportunities, drivers, industry-specific challenges and risks .
To project the consumption of Meningococcal Vaccine submarkets, with respect to key regions along with their respective key countries .
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

2019-2024 Global Meningococcal Vaccine Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Meningococcal Vaccine Consumption 2014-2024
2.1.2 Meningococcal Vaccine Consumption CAGR by Region
2.2 Meningococcal Vaccine Segment by Type
2.2.1 Quadrivalent
2.2.2 Bivalent
2.2.3 Others
2.3 Meningococcal Vaccine Consumption by Type
2.3.1 Global Meningococcal Vaccine Consumption Market Share by Type 2014-2019
2.3.2 Global Meningococcal Vaccine Revenue and Market Share by Type 2014-2019
2.3.3 Global Meningococcal Vaccine Sale Price by Type 2014-2019
2.4 Meningococcal Vaccine Segment by Application
2.4.1 Pneumonia
2.4.2 Meningitis
2.4.3 Bacteremia
2.4.4 Others Arthritis, Conjunctivitis, Urethritis
2.5 Meningococcal Vaccine Consumption by Application
2.5.1 Global Meningococcal Vaccine Consumption Market Share by Application 2014-2019
2.5.2 Global Meningococcal Vaccine Value and Market Share by Application 2014-2019
2.5.3 Global Meningococcal Vaccine Sale Price by Application 2014-2019

3 Global Meningococcal Vaccine by Players
3.1 Global Meningococcal Vaccine Sales Market Share by Players
3.1.1 Global Meningococcal Vaccine Sales by Players 2017-2019
3.1.2 Global Meningococcal Vaccine Sales Market Share by Players 2017-2019
3.2 Global Meningococcal Vaccine Revenue Market Share by Players
3.2.1 Global Meningococcal Vaccine Revenue by Players 2017-2019
3.2.2 Global Meningococcal Vaccine Revenue Market Share by Players 2017-2019
3.3 Global Meningococcal Vaccine Sale Price by Players
3.4 Global Meningococcal Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Meningococcal Vaccine Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Meningococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio CR3, CR5 and CR10 2017-2019
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Meningococcal Vaccine by Regions
4.1 Meningococcal Vaccine by Regions
4.1.1 Global Meningococcal Vaccine Consumption by Regions
4.1.2 Global Meningococcal Vaccine Value by Regions
4.2 Americas Meningococcal Vaccine Consumption Growth
4.3 APAC Meningococcal Vaccine Consumption Growth
4.4 Europe Meningococcal Vaccine Consumption Growth
4.5 Middle East & Africa Meningococcal Vaccine Consumption Growth

5 Americas
5.1 Americas Meningococcal Vaccine Consumption by Countries
5.1.1 Americas Meningococcal Vaccine Consumption by Countries 2014-2019
5.1.2 Americas Meningococcal Vaccine Value by Countries 2014-2019
5.2 Americas Meningococcal Vaccine Consumption by Type
5.3 Americas Meningococcal Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Meningococcal Vaccine Consumption by Countries
6.1.1 APAC Meningococcal Vaccine Consumption by Countries 2014-2019
6.1.2 APAC Meningococcal Vaccine Value by Countries 2014-2019
6.2 APAC Meningococcal Vaccine Consumption by Type
6.3 APAC Meningococcal Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Meningococcal Vaccine by Countries
7.1.1 Europe Meningococcal Vaccine Consumption by Countries 2014-2019
7.1.2 Europe Meningococcal Vaccine Value by Countries 2014-2019
7.2 Europe Meningococcal Vaccine Consumption by Type
7.3 Europe Meningococcal Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Meningococcal Vaccine by Countries
8.1.1 Middle East & Africa Meningococcal Vaccine Consumption by Countries 2014-2019
8.1.2 Middle East & Africa Meningococcal Vaccine Value by Countries 2014-2019
8.2 Middle East & Africa Meningococcal Vaccine Consumption by Type
8.3 Middle East & Africa Meningococcal Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Meningococcal Vaccine Distributors
10.3 Meningococcal Vaccine Customer

11 Global Meningococcal Vaccine Market Forecast
11.1 Global Meningococcal Vaccine Consumption Forecast 2019-2024
11.2 Global Meningococcal Vaccine Forecast by Regions
11.2.1 Global Meningococcal Vaccine Forecast by Regions 2019-2024
11.2.2 Global Meningococcal Vaccine Value Forecast by Regions 2019-2024
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Meningococcal Vaccine Forecast by Type
11.8 Global Meningococcal Vaccine Forecast by Application

12 Key Players Analysis
12.1 Novartis
12.1.1 Company Details
12.1.2 Meningococcal Vaccine Product Offered
12.1.3 Novartis Meningococcal Vaccine Sales, Revenue, Price and Gross Margin 2017-2019
12.1.4 Main Business Overview
12.1.5 Novartis News
12.2 GSK
12.2.1 Company Details
12.2.2 Meningococcal Vaccine Product Offered
12.2.3 GSK Meningococcal Vaccine Sales, Revenue, Price and Gross Margin 2017-2019
12.2.4 Main Business Overview
12.2.5 GSK News
12.3 Merck
12.3.1 Company Details
12.3.2 Meningococcal Vaccine Product Offered
12.3.3 Merck Meningococcal Vaccine Sales, Revenue, Price and Gross Margin 2017-2019
12.3.4 Main Business Overview
12.3.5 Merck News
12.4 CSL
12.4.1 Company Details
12.4.2 Meningococcal Vaccine Product Offered
12.4.3 CSL Meningococcal Vaccine Sales, Revenue, Price and Gross Margin 2017-2019
12.4.4 Main Business Overview
12.4.5 CSL News
12.5 Baxter
12.5.1 Company Details
12.5.2 Meningococcal Vaccine Product Offered
12.5.3 Baxter Meningococcal Vaccine Sales, Revenue, Price and Gross Margin 2017-2019
12.5.4 Main Business Overview
12.5.5 Baxter News
12.6 JN International Medical Corporation
12.6.1 Company Details
12.6.2 Meningococcal Vaccine Product Offered
12.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, Price and Gross Margin 2017-2019
12.6.4 Main Business Overview
12.6.5 JN International Medical Corporation News
12.7 Serum Institute of India
12.7.1 Company Details
12.7.2 Meningococcal Vaccine Product Offered
12.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue, Price and Gross Margin 2017-2019
12.7.4 Main Business Overview
12.7.5 Serum Institute of India News
12.8 Bio-Med
12.8.1 Company Details
12.8.2 Meningococcal Vaccine Product Offered
12.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue, Price and Gross Margin 2017-2019
12.8.4 Main Business Overview
12.8.5 Bio-Med News
12.9 China National Biotec Group
12.9.1 Company Details
12.9.2 Meningococcal Vaccine Product Offered
12.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue, Price and Gross Margin 2017-2019
12.9.4 Main Business Overview
12.9.5 China National Biotec Group News
12.10 Hualan Bio
12.10.1 Company Details
12.10.2 Meningococcal Vaccine Product Offered
12.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin 2017-2019
12.10.4 Main Business Overview
12.10.5 Hualan Bio News
12.11 Walvax
12.12 Zhifei

13 Research Findings and Conclusion
List of Tables and Figures

Figure Picture of Meningococcal Vaccine
Table Product Specifications of Meningococcal Vaccine
Figure Meningococcal Vaccine Report Years Considered
Figure Market Research Methodology
Figure Global Meningococcal Vaccine Consumption Growth Rate 2014-2024 (K Dose)
Figure Global Meningococcal Vaccine Value Growth Rate 2014-2024 ($ Millions)
Table Meningococcal Vaccine Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of Quadrivalent
Table Major Players of Quadrivalent
Figure Product Picture of Bivalent
Table Major Players of Bivalent
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2014-2019)
Table Global Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Figure Global Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Table Global Meningococcal Vaccine Revenue by Type (2014-2019) ($ million)
Table Global Meningococcal Vaccine Value Market Share by Type (2014-2019) ($ Millions)
Figure Global Meningococcal Vaccine Value Market Share by Type (2014-2019)
Table Global Meningococcal Vaccine Sale Price by Type (2014-2019)
Figure Meningococcal Vaccine Consumed in Pneumonia
Figure Global Meningococcal Vaccine Market: Pneumonia (2014-2019) (K Dose)
Figure Global Meningococcal Vaccine Market: Pneumonia (2014-2019) ($ Millions)
Figure Global Pneumonia YoY Growth ($ Millions)
Figure Meningococcal Vaccine Consumed in Meningitis
Figure Global Meningococcal Vaccine Market: Meningitis (2014-2019) (K Dose)
Figure Global Meningococcal Vaccine Market: Meningitis (2014-2019) ($ Millions)
Figure Global Meningitis YoY Growth ($ Millions)
Figure Meningococcal Vaccine Consumed in Bacteremia
Figure Global Meningococcal Vaccine Market: Bacteremia (2014-2019) (K Dose)
Figure Global Meningococcal Vaccine Market: Bacteremia (2014-2019) ($ Millions)
Figure Global Bacteremia YoY Growth ($ Millions)
Figure Meningococcal Vaccine Consumed in Others (Arthritis, Conjunctivitis, Urethritis)
Figure Global Meningococcal Vaccine Market: Others (Arthritis, Conjunctivitis, Urethritis) (2014-2019) (K Dose)
Figure Global Meningococcal Vaccine Market: Others (Arthritis, Conjunctivitis, Urethritis) (2014-2019) ($ Millions)
Figure Global Others (Arthritis, Conjunctivitis, Urethritis) YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2014-2019)
Table Global Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Figure Global Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Table Global Meningococcal Vaccine Value by Application (2014-2019)
Table Global Meningococcal Vaccine Value Market Share by Application (2014-2019)
Figure Global Meningococcal Vaccine Value Market Share by Application (2014-2019)
Table Global Meningococcal Vaccine Sale Price by Application (2014-2019)
Table Global Meningococcal Vaccine Sales by Players (2017-2019) (K Dose)
Table Global Meningococcal Vaccine Sales Market Share by Players (2017-2019)
Figure Global Meningococcal Vaccine Sales Market Share by Players in 2017
Figure Global Meningococcal Vaccine Sales Market Share by Players in 2018
Table Global Meningococcal Vaccine Revenue by Players (2017-2019) ($ Millions)
Table Global Meningococcal Vaccine Revenue Market Share by Players (2017-2019)
Figure Global Meningococcal Vaccine Revenue Market Share by Players in 2017
Figure Global Meningococcal Vaccine Revenue Market Share by Players in 2018
Table Global Meningococcal Vaccine Sale Price by Players (2017-2019)
Figure Global Meningococcal Vaccine Sale Price by Players in 2018
Table Global Meningococcal Vaccine Manufacturing Base Distribution and Sales Area by Players
Table Players Meningococcal Vaccine Products Offered
Table Meningococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Meningococcal Vaccine Consumption by Regions 2014-2019 (K Dose)
Table Global Meningococcal Vaccine Consumption Market Share by Regions 2014-2019
Figure Global Meningococcal Vaccine Consumption Market Share by Regions 2014-2019
Table Global Meningococcal Vaccine Value by Regions 2014-2019 ($ Millions)
Table Global Meningococcal Vaccine Value Market Share by Regions 2014-2019
Figure Global Meningococcal Vaccine Value Market Share by Regions 2014-2019
Figure Americas Meningococcal Vaccine Consumption 2014-2019 (K Dose)
Figure Americas Meningococcal Vaccine Value 2014-2019 ($ Millions)
Figure APAC Meningococcal Vaccine Consumption 2014-2019 (K Dose)
Figure APAC Meningococcal Vaccine Value 2014-2019 ($ Millions)
Figure Europe Meningococcal Vaccine Consumption 2014-2019 (K Dose)
Figure Europe Meningococcal Vaccine Value 2014-2019 ($ Millions)
Figure Middle East & Africa Meningococcal Vaccine Consumption 2014-2019 (K Dose)
Figure Middle East & Africa Meningococcal Vaccine Value 2014-2019 ($ Millions)
Table Americas Meningococcal Vaccine Consumption by Countries (2014-2019) (K Dose)
Table Americas Meningococcal Vaccine Consumption Market Share by Countries (2014-2019)
Figure Americas Meningococcal Vaccine Consumption Market Share by Countries in 2018
Table Americas Meningococcal Vaccine Value by Countries (2014-2019) ($ Millions)
Table Americas Meningococcal Vaccine Value Market Share by Countries (2014-2019)
Figure Americas Meningococcal Vaccine Value Market Share by Countries in 2018
Table Americas Meningococcal Vaccine Consumption by Type (2014-2019) (K Dose)
Table Americas Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Figure Americas Meningococcal Vaccine Consumption Market Share by Type in 2018
Table Americas Meningococcal Vaccine Consumption by Application (2014-2019) (K Dose)
Table Americas Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Figure Americas Meningococcal Vaccine Consumption Market Share by Application in 2018
Figure United States Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure United States Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Canada Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Canada Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Mexico Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Mexico Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Table APAC Meningococcal Vaccine Consumption by Countries (2014-2019) (K Dose)
Table APAC Meningococcal Vaccine Consumption Market Share by Countries (2014-2019)
Figure APAC Meningococcal Vaccine Consumption Market Share by Countries in 2018
Table APAC Meningococcal Vaccine Value by Countries (2014-2019) ($ Millions)
Table APAC Meningococcal Vaccine Value Market Share by Countries (2014-2019)
Figure APAC Meningococcal Vaccine Value Market Share by Countries in 2018
Table APAC Meningococcal Vaccine Consumption by Type (2014-2019) (K Dose)
Table APAC Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Figure APAC Meningococcal Vaccine Consumption Market Share by Type in 2018
Table APAC Meningococcal Vaccine Consumption by Application (2014-2019) (K Dose)
Table APAC Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Figure APAC Meningococcal Vaccine Consumption Market Share by Application in 2018
Figure China Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure China Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Japan Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Japan Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Korea Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Korea Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Southeast Asia Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Southeast Asia Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure India Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure India Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Australia Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Australia Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Table Europe Meningococcal Vaccine Consumption by Countries (2014-2019) (K Dose)
Table Europe Meningococcal Vaccine Consumption Market Share by Countries (2014-2019)
Figure Europe Meningococcal Vaccine Consumption Market Share by Countries in 2018
Table Europe Meningococcal Vaccine Value by Countries (2014-2019) ($ Millions)
Table Europe Meningococcal Vaccine Value Market Share by Countries (2014-2019)
Figure Europe Meningococcal Vaccine Value Market Share by Countries in 2018
Table Europe Meningococcal Vaccine Consumption by Type (2014-2019) (K Dose)
Table Europe Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Figure Europe Meningococcal Vaccine Consumption Market Share by Type in 2018
Table Europe Meningococcal Vaccine Consumption by Application (2014-2019) (K Dose)
Table Europe Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Figure Europe Meningococcal Vaccine Consumption Market Share by Application in 2018
Figure Germany Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Germany Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure France Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure France Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure UK Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure UK Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Italy Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Italy Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Russia Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Russia Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Spain Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Spain Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Table Middle East & Africa Meningococcal Vaccine Consumption by Countries (2014-2019) (K Dose)
Table Middle East & Africa Meningococcal Vaccine Consumption Market Share by Countries (2014-2019)
Figure Middle East & Africa Meningococcal Vaccine Consumption Market Share by Countries in 2018
Table Middle East & Africa Meningococcal Vaccine Value by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Meningococcal Vaccine Value Market Share by Countries (2014-2019)
Figure Middle East & Africa Meningococcal Vaccine Value Market Share by Countries in 2018
Table Middle East & Africa Meningococcal Vaccine Consumption by Type (2014-2019) (K Dose)
Table Middle East & Africa Meningococcal Vaccine Consumption Market Share by Type (2014-2019)
Figure Middle East & Africa Meningococcal Vaccine Consumption Market Share by Type in 2018
Table Middle East & Africa Meningococcal Vaccine Consumption by Application (2014-2019) (K Dose)
Table Middle East & Africa Meningococcal Vaccine Consumption Market Share by Application (2014-2019)
Figure Middle East & Africa Meningococcal Vaccine Consumption Market Share by Application in 2018
Figure Egypt Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Egypt Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure South Africa Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure South Africa Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Israel Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Israel Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure Turkey Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure Turkey Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Figure GCC Countries Meningococcal Vaccine Consumption Growth 2014-2019 (K Dose)
Figure GCC Countries Meningococcal Vaccine Value Growth 2014-2019 ($ Millions)
Table Meningococcal Vaccine Distributors List
Table Meningococcal Vaccine Customer List
Figure Global Meningococcal Vaccine Consumption Growth Rate Forecast (2019-2024) (K Dose)
Figure Global Meningococcal Vaccine Value Growth Rate Forecast (2019-2024) ($ Millions)
Table Global Meningococcal Vaccine Consumption Forecast by Countries (2019-2024) (K Dose)
Table Global Meningococcal Vaccine Consumption Market Forecast by Regions
Table Global Meningococcal Vaccine Value Forecast by Countries (2019-2024) ($ Millions)
Table Global Meningococcal Vaccine Value Market Share Forecast by Regions
Figure Americas Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Americas Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure APAC Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure APAC Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Europe Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Europe Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Middle East & Africa Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Middle East & Africa Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure United States Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure United States Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Canada Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Canada Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Mexico Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Mexico Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Brazil Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Brazil Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure China Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure China Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Japan Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Japan Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Korea Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Korea Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Southeast Asia Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Southeast Asia Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure India Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure India Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Australia Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Australia Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Germany Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Germany Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure France Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure France Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure UK Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure UK Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Italy Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Italy Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Russia Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Russia Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Spain Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Spain Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Egypt Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Egypt Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure South Africa Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure South Africa Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Israel Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Israel Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure Turkey Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure Turkey Meningococcal Vaccine Value 2019-2024 ($ Millions)
Figure GCC Countries Meningococcal Vaccine Consumption 2019-2024 (K Dose)
Figure GCC Countries Meningococcal Vaccine Value 2019-2024 ($ Millions)
Table Global Meningococcal Vaccine Consumption Forecast by Type (2019-2024) (K Dose)
Table Global Meningococcal Vaccine Consumption Market Share Forecast by Type (2019-2024)
Table Global Meningococcal Vaccine Value Forecast by Type (2019-2024) ($ Millions)
Table Global Meningococcal Vaccine Value Market Share Forecast by Type (2019-2024)
Table Global Meningococcal Vaccine Consumption Forecast by Application (2019-2024) (K Dose)
Table Global Meningococcal Vaccine Consumption Market Share Forecast by Application (2019-2024)
Table Global Meningococcal Vaccine Value Forecast by Application (2019-2024) ($ Millions)
Table Global Meningococcal Vaccine Value Market Share Forecast by Application (2019-2024)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Novartis Meningococcal Vaccine Market Share (2017-2019)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure GSK Meningococcal Vaccine Market Share (2017-2019)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Merck Meningococcal Vaccine Market Share (2017-2019)
Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure CSL Meningococcal Vaccine Market Share (2017-2019)
Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Baxter Meningococcal Vaccine Market Share (2017-2019)
Table JN International Medical Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure JN International Medical Corporation Meningococcal Vaccine Market Share (2017-2019)
Table Serum Institute of India Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Serum Institute of India Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Serum Institute of India Meningococcal Vaccine Market Share (2017-2019)
Table Bio-Med Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bio-Med Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bio-Med Meningococcal Vaccine Market Share (2017-2019)
Table China National Biotec Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table China National Biotec Group Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure China National Biotec Group Meningococcal Vaccine Market Share (2017-2019)
Table Hualan Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Hualan Bio Meningococcal Vaccine Market Share (2017-2019)
Table Walvax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zhifei Basic Information, Manufacturing Base, Sales Area and Its Competitors
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....